Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$8.71 - $10.72 $772,620 - $950,917
-88,705 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$9.2 - $23.86 $534,529 - $1.39 Million
-58,101 Reduced 39.58%
88,705 $877,000
Q4 2020

Feb 16, 2021

SELL
$13.47 - $24.89 $237,072 - $438,064
-17,600 Reduced 10.71%
146,806 $3.39 Million
Q3 2020

Nov 04, 2020

SELL
$12.89 - $15.89 $507,866 - $626,066
-39,400 Reduced 19.33%
164,406 $2.32 Million
Q2 2020

Jul 31, 2020

SELL
$8.86 - $15.69 $400,472 - $709,188
-45,200 Reduced 18.15%
203,806 $3.07 Million
Q1 2020

May 08, 2020

BUY
$6.63 - $11.16 $138,567 - $233,244
20,900 Added 9.16%
249,006 $2.3 Million
Q4 2019

Feb 11, 2020

BUY
$7.48 - $10.75 $41,140 - $59,125
5,500 Added 2.47%
228,106 $2.22 Million
Q3 2019

Nov 01, 2019

BUY
$8.02 - $13.25 $97,042 - $160,325
12,100 Added 5.75%
222,606 $1.79 Million
Q2 2019

Aug 13, 2019

BUY
$10.96 - $14.4 $1.49 Million - $1.95 Million
135,601 Added 181.03%
210,506 $2.63 Million
Q1 2019

May 15, 2019

SELL
$10.04 - $13.92 $1.48 Million - $2.05 Million
-147,000 Reduced 66.24%
74,905 $1.02 Million
Q1 2019

May 13, 2019

BUY
$10.04 - $13.92 $1.48 Million - $2.06 Million
147,800 Added 199.45%
221,905 $1.37 Million
Q4 2018

Feb 14, 2019

BUY
$8.38 - $13.44 $45,863 - $73,557
5,473 Added 7.97%
74,105 $710,000
Q3 2018

Nov 14, 2018

BUY
$11.6 - $16.54 $49,880 - $71,122
4,300 Added 6.68%
68,632 $830,000
Q2 2018

Aug 06, 2018

SELL
$13.13 - $17.09 $22,321 - $29,053
-1,700 Reduced 2.57%
64,332 $1 Million
Q1 2018

May 03, 2018

BUY
$13.76 - $17.12 $908,600 - $1.13 Million
66,032 New
66,032 $993,000

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.77B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Mackay Shields LLC Portfolio

Follow Mackay Shields LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mackay Shields LLC with notifications on news.